- Home
- CDTX vs NXDT Comparison
CDTX vs NXDT Comparison
Compare CDTX & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- NXDT
- Stock Information
- Founded
- CDTX 2012
- NXDT 2012
- Country
- CDTX United States
- NXDT United States
- Employees
- CDTX N/A
- NXDT N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- NXDT Investment Managers
- Sector
- CDTX Health Care
- NXDT Finance
- Exchange
- CDTX Nasdaq
- NXDT Nasdaq
- Market Cap
- CDTX 259.0M
- NXDT 156.8M
- IPO Year
- CDTX 2015
- NXDT N/A
- Fundamental
- Price
- CDTX $17.82
- NXDT $3.73
- Analyst Decision
- CDTX Strong Buy
- NXDT
- Analyst Count
- CDTX 8
- NXDT 0
- Target Price
- CDTX $38.00
- NXDT N/A
- AVG Volume (30 Days)
- CDTX 156.0K
- NXDT 133.6K
- Earning Date
- CDTX 05-14-2025
- NXDT 01-01-0001
- Dividend Yield
- CDTX N/A
- NXDT 9.66%
- EPS Growth
- CDTX N/A
- NXDT N/A
- EPS
- CDTX N/A
- NXDT 0.99
- Revenue
- CDTX $1,275,000.00
- NXDT N/A
- Revenue This Year
- CDTX N/A
- NXDT N/A
- Revenue Next Year
- CDTX N/A
- NXDT N/A
- P/E Ratio
- CDTX N/A
- NXDT $6.41
- Revenue Growth
- CDTX N/A
- NXDT N/A
- 52 Week Low
- CDTX $10.00
- NXDT $5.89
- 52 Week High
- CDTX $28.42
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- CDTX 33.85
- NXDT 32.74
- Support Level
- CDTX $19.83
- NXDT $3.69
- Resistance Level
- CDTX $23.76
- NXDT $3.94
- Average True Range (ATR)
- CDTX 1.58
- NXDT 0.26
- MACD
- CDTX -0.53
- NXDT 0.01
- Stochastic Oscillator
- CDTX 5.11
- NXDT 29.67
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.